IPP Bureau
Novartis unveils new focused strategy
By IPP Bureau - September 27, 2022
Transformation to pure-play Innovative Medicines company nears completion
CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy
By IPP Bureau - September 27, 2022
NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
By IPP Bureau - September 26, 2022
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
Alkem to spread awareness through “The Healthy Lungs”
By IPP Bureau - September 26, 2022
Though lungs do not have the celebrity status as the heart, they are one of the most important and delicate organs of the human body
Puneet Sud appointed additional director of Nectar Lifesciences
By IPP Bureau - September 26, 2022
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
Kiran Mazumdar-Shaw awarded H. K. Firodia Lifetime Achievement Award 2022
By IPP Bureau - September 26, 2022
The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship
AIIMS New Delhi celebrates 67th Foundation Day
By IPP Bureau - September 26, 2022
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
Aptar Pharma collaborates with Fluidda
By IPP Bureau - September 25, 2022
The companies will leverage their respective proprietary technology platforms
Unichem Laboratories sale its stake in Optimus Drugs
By IPP Bureau - September 24, 2022
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Cadila and CII launches joint national campaign for rabies-free India by 2030
By IPP Bureau - September 24, 2022
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
JB Pharma rolls out its campaign #Heart2HeartChallengeIndia
By IPP Bureau - September 24, 2022
The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health
Bausch and Glenmark announce approval of RYALTRIS in Canada
By IPP Bureau - September 24, 2022
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals
By IPP Bureau - September 24, 2022
The startup plans to provide free technology to dental clinics upon registration.
Madhavbaug plans to foray in UAE, Europe & US
By IPP Bureau - September 24, 2022
To set up 50 lifestyle modification centres across the UAE in the next 24 months
India achieves significant landmark in reduction of child mortality rates
By IPP Bureau - September 24, 2022
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
